[HTML][HTML] Therapeutic strategies for targeting IL-1 in cancer

A Gottschlich, S Endres, S Kobold - Cancers, 2021 - mdpi.com
Simple Summary Interleukin-1 cytokines are key proinflammatory cytokines which have
been implicated with differing pro-and antitumorigenic properties. Recent years have …

Therapeutic Strategies for Targeting IL-1 in Cancer

A Gottschlich, S Endres, S Kobold - Cancers, 2021 - pubmed.ncbi.nlm.nih.gov
Since its discovery, interleukin-1 has been extensively studied in a wide range of medical
fields. Besides carrying out vital physiological functions, it has been implicated with a pivotal …

Therapeutic Strategies for Targeting IL-1 in Cancer.

A Gottschlich, S Endres, S Kobold, C Alfaro - Cancers, 2021 - search.ebscohost.com
Abstract Simple Summary: Interleukin-1 cytokines are key proinflammatory cytokines which
have been implicated with differing pro-and antitumorigenic properties. Recent years have …

[HTML][HTML] Therapeutic Strategies for Targeting IL-1 in Cancer

A Gottschlich, S Endres, S Kobold - Cancers, 2021 - ncbi.nlm.nih.gov
Since its discovery, interleukin-1 has been extensively studied in a wide range of medical
fields. Besides carrying out vital physiological functions, it has been implicated with a pivotal …

Therapeutic Strategies for Targeting IL-1 in Cancer.

A Gottschlich, S Endres, S Kobold - Cancers, 2021 - europepmc.org
Since its discovery, interleukin-1 has been extensively studied in a wide range of medical
fields. Besides carrying out vital physiological functions, it has been implicated with a pivotal …

Therapeutic Strategies for Targeting IL-1 in Cancer

A Gottschlich, S Endres, S Kobold - Cancers, 2021 - epub.ub.uni-muenchen.de
Interleukin-1 cytokines are key proinflammatory cytokines which have been implicated with
differing pro-and antitumorigenic properties. Recent years have brought exciting insights …